Aehr Test Systems

As of May 31, 2026, Aehr Test Systems carries a market capitalization of 2.79B, placing it among publicly traded companies globally. Its enterprise value stands at 2.70B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Aehr Test Systems's next confirmed earnings release is scheduled for October 22, 2026.

As of May 31, 2026, Aehr Test Systems has 32.48M shares outstanding.

These figures are as of May 31, 2026. The price-to-sales ratio is 61.52, and the price-to-book ratio stands at 14.84.

These figures are as of May 31, 2026. The EV/Sales ratio of 63.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 2.70B versus a market cap of 2.79B, with the gap driven by net debt and cash on the balance sheet.

As of May 31, 2026, Aehr Test Systems maintains a current ratio of 10.33, meaning it holds 10.3x the short-term assets needed to cover near-term liabilities.

Over the twelve months ended May 31, 2026, Aehr Test Systems posted a negative return on equity (ROE) of -4.16, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.61, reflecting losses generated across the asset base. The company generates approximately 314,218.74 in revenue per employee across its workforce of 136.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.78 indicates how many times Aehr Test Systems sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended May 31, 2026, Aehr Test Systems recorded an income tax benefit of -3.95M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -10.07M and -6.11M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Aehr Test Systems's stock has gained approximately 135.93% over the past 52 weeks. The 50-day moving average sits at 79.40, while the 200-day moving average is 63.86.

Over the twelve months ended May 31, 2026, Aehr Test Systems generated 42.89M in revenue and converted that into -6.11M in net income, yielding earnings per share of -0.20. EBITDA reached -9.11M, while operating income came in at -12.13M.

As of May 31, 2026, Aehr Test Systems holds 99.81M in cash and equivalents against 8.48M in total debt, resulting in a net debt position of -99.81M. Total book value stands at 188.30M, with working capital of 142.90M providing operational flexibility.

Aehr Test Systems produced -2.84M in operating cash flow over the twelve months ended May 31, 2026. After subtracting -1.77M in capital expenditures, free cash flow totaled -4.61M - equivalent to -0.15 per share.

Over the twelve months ended May 31, 2026, Aehr Test Systems posted a gross margin of 35.30, reflecting its pricing power and cost economics. The operating margin of -28.29 and net profit margin of -14.25 provide insight into operational efficiency.

These figures cover the twelve months ended May 31, 2026. Free cash flow yield is negative at -0.17: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -2.98, meaning Aehr Test Systems raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of May 31, 2026, Aehr Test Systems has an Altman Z-Score of 72.62, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.